G229-0411 Screening compound: 1-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-4-[3-(2-PYRIDYL)-1,2,4-OXADIAZOL-5-YL]-2-PYRROLIDINONE

G229-0411 Screening compound: 1-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-4-[3-(2-PYRIDYL)-1,2,4-OXADIAZOL-5-YL]-2-PYRROLIDINONE
G229-0411 Screening compound: 1-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-4-[3-(2-PYRIDYL)-1,2,4-OXADIAZOL-5-YL]-2-PYRROLIDINONE alternative view

Chemical Structure Depiction of ChemDiv screening compound G229-0411
1-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-4-[3-(2-PYRIDYL)-1,2,4-OXADIAZOL-5-YL]-2-PYRROLIDINONE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G229-0411

Molecular Formula

C19H16N4O4 (C19 H16 N4 O4)

Compound Name

1-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-4-[3-(2-PYRIDYL)-1,2,4-OXADIAZOL-5-YL]-2-PYRROLIDINONE

IUPAC name

1-(23-dihydro-14-benzodioxin-6-yl)-4-[3-(pyridin-2-yl)-124-oxadiazol-5-yl]pyrrolidin-2-one

SMILES

O=C(CC(C1)c2nc(-c3ncccc3)no2)N1c(cc1)cc2c1OCCO2

InChI

InChI=1S/C19H16N4O4/c24-17-9-12(19-21-18(22-27-19)14-3-1-2-6-20-14)11-23(17)13-4-5-15-16(10-13)26-8-7-25-15/h1-6,10,12H,7-9,11H2/t12-/m1/s1

InChI Key

ZVVYNKLLJSXLRZ-GFCCVEGCSA-N

MDL Number (MFCD)

MFCD14222281

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

364.36

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

3.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

1.604

Distribution Coefficient, logD

1.604

Water Solubility, LogSw

-1.88

Polar Surface Area

73.265

Acid Dissociation Constant (pKa)

11.87

Base Dissociation Constant (pKb)

2.75

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

26.32

G229-0411 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

GPCR Targeted Library (31838 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with G229-0411 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G229-0411?
Check Price and Availability of G229-0411, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G229-0411 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G229-0411
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G229-0411
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G229-0411 available by request